Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years-Reference-Cited by-同舟云学术

Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years

Published:2022-05 Issue: Volume:61 Page:103777
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Ghadiri Fereshteh,Sahraian Mohammad Ali,Baghbanian Seyed Mohammad,Ashtari Fereshteh,Razazian Nazanin,Majdinasab Nastaran,Poursadeghfard Maryam,Hatamian Hamidreza,Harirchian Mohammad Hossein,Beladimoghadam Nahid,Azimi Amirreza,Sharifipour Ehsan,Hosseini Samaneh,Bayati Asghar,Kamali Hoda,Hosseni Nejad Mir Nahid,Faraji Fardin,Mozhdehipanah Hossein,Modara Farhad,Navardi Samira,Heidari Hora,Ayoubi Saeideh,Naser Moghadasi Abdorreza^ORCID,Eskandarieh Sharareh

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference27 articles.

1. Use of disease-modifying therapies in pediatric relapsing-remitting multiple sclerosis in the United Kingdom;Abdel-Mannan;Neurol. Neuroimmunol. Neuroinflamm.,2021

2. Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis;Amato;Brain,2020

3. Late-onset multiple sclerosis is associated with an increased rate of reaching disability milestones (760);Andersen;Neurology,2020

4. Epidemiology of multiple sclerosis in Iran: a systematic review and meta-analysis;Azami;PLoS One,2019

5. Sclerose des cordons lateraux de la moelle epinere chez femmehysterique atteinte de contracture peranemte des quatre membres;Charcot;Bull. Soc. Med. Hop. Paris,1965

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal and spatial patterns in the prescriptions of disease-modifying therapies for multiple sclerosis. Results from the Italian Multiple Sclerosis and Related Disorders Register;Multiple Sclerosis and Related Disorders;2024-07

2. Exploring suicidal ideation prevalence in multiple sclerosis patients during the COVID-19 pandemic: A study on the relationship between drug use and suicidal ideation;Multiple Sclerosis and Related Disorders;2024-07

3. Consanguineous marriage among familial multiple sclerosis subjects: A national registry-based study;Heliyon;2024-06

4. Article Review: Multiple Sclerosis;Journal for Research in Applied Sciences and Biotechnology;2024-03-07

5. The disease-modifying therapy utilisation and cost trend for multiple sclerosis in Australia between 2013 and 2022;Multiple Sclerosis Journal;2023-11-24